Verseau Therapeutics

Repolarizing macrophages. Revolutionizing the treatment of cancer.

General Information
Company Name
Verseau Therapeutics
Founded Year
2017
Location (Offices)
Bedford, United States +1
Founders / Decision Makers
Number of Employees
6
Industries
-
Funding Stage
-
Social Media

Verseau Therapeutics - Company Profile

Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors. This is accomplished by stimulating macrophages to shift their phenotype from immunosuppressive to a pro-inflammatory, anti-tumor state in a process called macrophage repolarization. Verseau developed a unique target discovery engine that leveraged patient data and computational biology to discover and validate over 20 novel macrophage targets. Verseau’s first-in-class monoclonal antibody candidates, VTX-0811 targeting PSGL-1 and VTX-1218 targeting VSIG4, are in late preclinical development and progressing toward clinical trials.

Funding Rounds & Investors of Verseau Therapeutics (0)

View All

There is no investment information

Latest News of Verseau Therapeutics

View All

No recent news or press coverage available for Verseau Therapeutics.

Similar Companies to Verseau Therapeutics

View All
Elpiscience Biopharmaceuticals - Similar company to Verseau Therapeutics
Elpiscience Biopharmaceuticals Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies.
MACROPHAGE PHARMA LIMITED - Similar company to Verseau Therapeutics
MACROPHAGE PHARMA LIMITED Empowering the immune system to combat cancer with precision-targeted therapies
Deliver Pharma - Similar company to Verseau Therapeutics
Deliver Pharma Pioneering macrophage-targeting therapies for a healthier tomorrow.
Teclison - Similar company to Verseau Therapeutics
Teclison Biotechnology company that specializes in the development of innovative cancer medicines